Pascal Barollier | Chief Engagement & Information Officer
Gavi, The Vaccine Alliance

Pascal Barollier, Chief Engagement & Information Officer, Gavi, The Vaccine Alliance

Pascal Barollier is Gavi’s Chief Engagement & Information Officer, leading a multidisciplinary team of experts in public policy and advocacy; communications; knowledge management, data and information technology; and measurement, evaluation and learning.  He is passionate about using cutting-edge technology and data analytics to deliver impactful and transparent results in Gavi’s strategic goals of increasing immunisation coverage, equity and sustainability in lower-income countries.
Pascal is a certified Board Director with a diploma from the International Institute for Management Development (IMD) in Lausanne.
Before joining Gavi in 2013, Pascal was Vice President of global external communications at Sanofi Pasteur, one of the largest global vaccine manufacturers. He also coordinated Sanofi’s global communications during the 2009–2010 influenza pandemic. 
Previously, Pascal was a journalist for Agence France-Presse (AFP) for 18 years from Paris, Washington, DC and other locations around the world. 
Pascal has co-founded a magazine and web agency specialised in digital content. He is the author of three novels published by Flammarion, co-author of an essay about life in Sarajevo during the war in the former Yugoslavia and has authored several scripts for feature films.
Pascal was the recipient of a fellowship to attend Indiana University’s Master’s degree programme at the Ernie Pyle School of Journalism, where he also served as a teaching assistant in photojournalism. Previously, he graduated from the Institut d’études politiques (Sciences Po) in Strasbourg, with a major in Public Administration. He has also received executive education from ESMT Berlin business school.

Appearances:



Main Congress Day 3 - 24th April @ 11:30

Panel: What happened with the political will to inoculate the world? Funding and support for infectious disease vaccine development

  • What would a new model look like for innovative vaccine development so that we do not rely on reactive funding and resources?
  • Importance of communications and trust – esp. when you have different vaccine options
  • Could we be leveraging “warm places” to support NTDs and tackle local diseases with these distributed plants?
  • How to keep this sustainable even when governments change and during war?
  • How are available resources being used to address gaps in the pipeline or supply chain that are a barrier to access?

Main Congress Day 3 - 24th April @ 13:35

Keynote panel: The role of vaccines in a changing world…priorities, strategies, communications, and behavioral science

  • What are the areas of opportunity to transform global health?  Strategic goals from now to 2030
  • Perception of safety
  • Cultural differences
  • Application of behavioral science to improve vaccine uptake
  • Translating behavioral science insights into improved crisis communication & risk management strategies
last published: 17/Feb/25 16:05 GMT

back to speakers